A Double-Blind, Placebo-Controlled Study of Selegiline Transdermal System in Depressed Adolescents

Abstract

These data demonstrated that the STS was safe and well tolerated in this adolescent sample. However, both STS-treated and placebo-treated subjects demonstrated a decline from baseline in depressive symptoms (CDRS-R total score) over the length of the study, without statistical superiority by either group.